This paper reports the results of two surveys of all UK. rheumatologists conducted in 1993 and 1995. Results are presented by regional health authority and by country. During the 2 yr, there has been a rise in the number of consultants, but a fall in the proportion doing rheumatology combined with rehabilitation. Consultants are working harder-doing more clinics and seeing more patients. Regional disparities in service provision persist, but are slowly diminishing. On the whole, the south of the country is better provided with consultants, but has fewer in-patient facilities, while the reverse is true in the north.
THE British League against Rheumatism established a register of all consultant rheumatologists in the UK in 1971. The register is now run under the joint auspices of the Arthritis and Rheumatism Council (ARC) and British Society for Rheumatology (BSR) . The data held on the register are updated biennially. Over the years, various publications [1, 2] have highlighted the uneven distribution of rheumatologists around the UK. At the time of the last published review in 1990 [2] , there were still 18 (9%) district health authorities in England and Wales with no rheumatology sessions, and a further 16 (8%) with fewer than three sessions per week. At that time, the most undermanned regions were Wales, Yorkshire, North Western and Mersey. By contrast, all district health authorities in North East Thames, Wessex and Oxford had at least three rheumatology sessions per week.
The 1990 NHS and Community Care Act has led to fundamental changes in the delivery of health care. Purchasers of health care are now required to build up a profile of the health care needs of their local population and to direct their resources to address these needs. There is no obligation for them to purchase services from their local provider unit. We have, therefore, moved away from a time in which it was appropriate to look at rheumatology services purely in terms of sessions per unit of the local population. This paper reports the results of surveys conducted ~2 and 4 yr after the enactment of the NHS and Community Care Act. It looks at the work patterns of individual rheumatologists and at the services available within regions (rather than districts, as previously). In 1994, the original 14 regional health authorities of England were abolished and replaced by eight regional offices of the NHS management executive. For the sake of continuity, the 1994 manpower data are presented both by the old regions and the new regional offices.
METHODS
In January 1993 and January 1995, at the request of the BSR Clinical Affairs Committee, all consultants on the ARC/BSR Manpower Register were sent questionnaires concerning their patterns of practice. The questions were divided into those applying to the individual, which were concerned with workload (e.g. numbers of clinics, number of patients seen) and those applying to the institution concerning facilities (e.g. numbers of beds, paramedical staff) ( Table I ). Only one mailing was sent in 1993, but a reminder was sent to non-responders in the 1995 survey.
The results, which are presented by regional health authority, have been extrapolated to adjust for those consultants who did not respond. Therefore, the most reliable estimates come from the regions with the highest response rate. Some questions (e.g. number of new out-patients seen) produced a lower response rate than others and so these figures have been subject to more adjustment.
The Royal College of Physicians recommended in 1988 that there should be one whole-time rheum- . We have interpreted this as a need for one weekly rheumatology session per 15 000 population. More recently, the BSR has produced a document, using epidemiologically based health care needs assessment methods, in which it estimated a need for one rheumatologist per 85 000 population, or one session per 8500 population [4] . The number of sessions required for each region has been estimated using both the RCP (one session per 15 000) and BSR (one session per 8500) proposals, and compared to the number of sessions actually provided. This latter figure was calculated using data from the two surveys and data held on the Manpower Register (which was updated at the time of both these surveys). In the absence of any other information, pure rheumatologists were assumed to work 10 rheumatology sessions per week, and those in rheumatology and general medicine, or rheumatology and rehabihtation, five rheumatology sessions per week.
RESULTS
A total of 341 questionnaires were mailed in 1993 and 356 in 1995. The response rate was higher for the 1995 survey, in which two mailings were sent (Table II) . Oxford had the highest response rate on both occasions and Northern Ireland had the lowest. In both surveys, female consultants had a higher response rate than males (Table III) , although the difference had lessened. The proportion of consultants working in rheumatology and rehabilitation appears to have fallen substantially in the 2 yr. There was no change in the proportion with full-time (~48%) and the proportion with maximum part-time contracts (~44%).
Working patterns of consultants
Nationwide, the average number of weekly clinics per consultant has increased from 3.8 in 1993 to 4.5 in 1995 (Table IV) . This pattern was found in all regions except East Anglia (Fig. 1) . In 1993, the average number of clinics was highest in the Northern Region (mean 4.8) and lowest in Northern Ireland (mean 2.6), whereas in 1995 the lowest was still in Northern Ireland (mean 3.0), but several regions had a similarly high average of around five clinics per week. The average number of ward rounds was unchanged.
When allowance was made for time spent in other specialties (usually general medicine or rehabihtation) by rheumatologists, the pattern changed. In 1993, in Wessex 87% of rheumatology sessions were devoted to out-patient clinics, whereas in the Mersey region only 32% of rheumatology sessions were spent in clinic (Fig. 2) . By 1995, consultants in the Oxford region were devoting the most time to out-patient clinics (69%) and those in Trent spent the lowest proportion of rheumatology sessions in the clinic (50%). multidisciplinary treatment followed by routine outpatient care or to receive the routine out-patient care only. Random allocation was achieved by means of randomly assorted cards which were placed in sealed envelopes in blocks of 10, and performed for women and men separately. Apart from the patients who were randomized, a third group of patients was studied, comprising those patients who fulfilled the inclusion criteria, but refused random allocation. All clinical data of this patient group were collected according to the study protocol. This group will be further indicated as the 'non-allocated patient group'.
In-patient treatment consisted of a fixed period of 11 days of hospitalization in a rheumatology clinic associated with the Leiden University Hospital shortly after study entry. The clinic is a referral centre with in-patient facilities for patients with rheumatic diseases from the district of Leiden (300 000 inhabitants) and surrounding districts (1 million inhabitants), and has 38 beds. Apart from primary nursing care, the treatment consisted of prescribed regimens of bed rest and a daily individual range of motion and muscle-strengthening exercise programme performed by the physical therapist. The occupational therapist provided information on the principles of joint protection, self-care, household and work activities. Joint splints, adaptive equipment and house adaptations were arranged for if necessary. The social worker discussed aspects related to coping with the disease and financial questions. Treatment goals and modalities were discussed during weekly multidisciplinary team conferences. In all study groups, DMARDs were introduced or changed shortly after study entry and during the whole study period non-steroidal anti-inflammatory drugs (NSAIDs) were optimized, intra-articular injections with corticosteroids were administered and DMARDs were changed if needed. During out-patient care, the prescription of drugs, paramedical treatment and splints was left to the attending physician at the out-patient clinic. In order to stay as close to daily practice as possible, no special attempts were made in either group to alter the treatment regimens normally employed in the out-patient setting.
Assessment methods
All patients were assessed at study entry, after 2 weeks (at discharge in the in-patient group), and at 4, 12 and 52 weeks. All assessments were done by the same physician (TPMV), who was not involved in the management of the patients, but could for practical reasons not be blinded to the patient's randomization status.
Measures of disease activity included the following. (1) The patient's estimation of severity of disease activity, pain and fatigue, all measured on a visual analogue scale (VAS). Morning stiffness was measured both by duration (minutes) and severity (VAS) [21] . (2) The physician's estimation of disease activity on a four-point scale, ranging from 0 = no disease activity to 3 = high disease activity. (3) The number of swollen joints; 20 joints were examined, including the temporomandibular joints, the sternoclavicular joints, the shoulders, elbows, wrists, knees and ankles. The proximal interphalangeal and metacarpophalangeal of each hand, and the metatarsophalangeal joints of each foot, were calculated as a single unit. (4) Emotional status was measured by the anxiety and depression items of the Dutch-Arthritis Impact Measurement Scales (AIMS) [24] .
Radiographs of both hands, wrists and feet were made at study entry and after 52 weeks of follow-up. All radiographs were assessed according to the criteria of Kellgren [25] by an independent reader (A. Cats) (maximum possible number of affected joints 50; maximum erosion score 200).
Health care costs were calculated for in-patients by review of the comprehensive hospital charges at the rheumatology clinic at the time the study was conducted. The use of health care services during out-patient management in all groups was determined from medical records and patient interviews.
Statistical analysis
To calculate the sample size, the patient's estimation of pain as measured with a VAS was chosen as the primary outcome measure for the present trial. A difference of 30% between the in-patient and the out-patient group according to the improvement in the first 2 weeks was arbitrarily considered to be a clinically important difference for the present trial. Assuming no change in the out-patient group during the first 2 weeks, and using Student's two-tailed Mest of the difference between two means with a = 0.05 and P = 0.20, a sample size of 36 in each group would be required to detect this difference.
Patients' characteristics at study entry and the use of medical and paramedical services during follow-up were compared by Mann-Whitney U or Pearson x 2 tests where appropriate. Differences between the groups according to changes from baseline at the different time points were analysed on an intention to treat basis, by multiple regression analysis, adjusting for small variations in baseline values and medical treatment. The ACR preliminary criteria for improvement [26] were used to define 'responders' and 'non-responders'. Patients were characterized as responders if they showed >20% improvement in both tender and swollen joint count, plus ^20% improvement in three out of five other ACR core set measures: patient and physician global assessments, patient pain, disability (HAQ score) and an acute phase reactant (ESR).
